GLP-1s are incretin-based agents that amplify glucose-stimulated insulin secretion, suppress inappropriate glucagon release, slow gastric emptying, and promote satiety
We provide continuous medical supervision, support, and coaching to help you reach your goal weight and successfully maintain it
Shapsis is a leader in non-surgical bariatric treatments, and Dr
Future research should also address optimal dosing, timing of intervention, and potential synergistic or antagonistic interactions with existing immunosuppressive therapiesareas that remain largely unexplored but could have major implications for clinical practice
Both methods have their strengths
A study in rats and mice found that semaglutide, a GLP-1 drug sold as Ozempic and Wegovy, may help curb alcohol consumption and reduce relapse-drinking behaviors